Related Experiment Video

Updated: Aug 17, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

[Body-weight regulation in children: a key to obesity physiopathology understanding]

P Tounian1

  • 1Service de gastro-entérologie et nutrition pédiatriques, hôpital d'enfants Armand-Trousseau, AP-HP, Paris, France. p.tounian@trs.ap-hop-paris.fr

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|March 31, 2004
PubMed

Insights

The body’s weight regulation system, the adipostat, defends against weight loss, explaining obesity treatment failures. Targeting this energy-regulating system offers a promising therapeutic strategy for obesity.

Area of Science:

  • Physiology
  • Neuroendocrinology
  • Metabolic Regulation

Context:

  • Body weight is maintained within a narrow range through a process called the adipostat.
  • Peripheral signals like leptin and ghrelin inform the hypothalamus about energy stores.
  • The hypothalamus regulates appetite and energy expenditure to maintain energy balance.

Purpose:

  • To explain the physiological mechanisms underlying body weight regulation.
  • To elucidate the role of the adipostat in maintaining stable body weight.
  • To understand why obesity treatments often fail due to the adipostat's resistance to weight loss.

Summary:

  • The adipostat system actively defends against weight loss by increasing appetite and reducing energy expenditure.
  • Obese individuals exhibit adipostat mechanisms that maintain elevated body weight.
  • This inherent resistance explains the common ineffectiveness of traditional obesity treatments.

Impact:

  • Understanding the adipostat's role provides insight into the challenges of obesity management.
  • Identifying the adipostat's resistance mechanisms opens avenues for novel therapeutic strategies.
  • Directly targeting the energy-regulating system may offer a more effective approach to treating obesity.

More Related Videos

Control of Eating Behavior Using a Novel Feedback System04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

Multidisciplinary Approach to Obesity Management: A Case Report05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Related Concept Videos

Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...